Type 2 diabetes is not uniform; it’s a mosaic of conditions, each with its own characteristics. Understanding these subtypes may improve treatment plans and help people manage their condition better.
Rigor académico, oficio periodístico
Artículos sobre Insulin
Mostrando 1 - 20 de 74 artículos
Ozempic generated A$21 billion of sales in 2023 alone. So how was it developed? And how are its new competitors, Mounjaro and Zepbound, different?
Healthcare workers in South Africa aren’t always well equipped to treat diabetes. This has devastating consequences for patients.
Find out the signs and symptoms of type 2 diabetes.
Researchers successfully treated diabetes in mice by engineering cells to make insulin in response to the music of Queen.
A new study suggests that adding salt to your food at the table is linked to an increased risk of type 2 diabetes. But caution is needed.
About one in six pregnant women in Australia are now diagnosed with gestational diabetes. Rates have more than doubled since the thresholds for diagnosis were changed.
The shortages, which have been going on for years, have typically affected only low-cost generics rather than profitable brand-name drugs.
The drugmaker’s move responded to the growing competition that has shaken up the insulin market in recent years.
For parents, encouraging healthy family diets for children from the time they are babies is one way to keep children’s blood sugar levels in check. The Indonesian government can do more to help too.
Impaired insulin receptors in the blood vessels between the blood and the brain may contribute to the insulin resistance observed in Alzheimer’s disease.
On the centenary of insulin’s first use, doctors, researchers and people with diabetes are asking why New Zealand lags other countries in funding the latest devices to monitor blood sugar.
In Canada, 14.4 per cent of South Asians have Type 2 diabetes, the highest prevalence of any other ethnic group in the country. Why is this population so disproportionately affected by diabetes?
Improving diabetes care in South Africa requires strong will and support from health authorities, introduction of clinical information systems, the use of technology and digital solutions.
As diabetes progresses, insulin injections become the only treatment option. But the transition from oral medication to injectable insulin is often a bumpy one.
Proponents of intermittent fasting say the clock can help you win the battle of the bulge. But the science behind it is a little more complicated.
About 1 in 4 Americans with diabetes who need insulin struggle to pay for this lifesaving drug.
Fat cells and cancer cells talk to each other. Specialists in both systems can do the same.
The audio version of an in-depth article on the feuding scientists who battled for credit over the discovery of insulin.
Meet the feuding scientists who battled for credit over the discovery of insulin.
Principales colaboradores
-
Project Manager, University of Pretoria Diabetes Research Centre, University of Pretoria
-
Emeritus Robert Reford Professor and Professor of Medicine, McGill University
-
Professor of Medicine, Monash University
-
Lead for Evidence-Based Medicine and Nutrition, Aston Medical School, Aston University
-
Author and Honorary Fellow, School of Philosophy, Religion and History of Science, University of Leeds
-
Associate professor, Department of Biology and Institute of Biochemistry, Carleton University
-
Project Head, Tshwane Insulin Project, University of Pretoria
-
Chair in Zoology, University of Aberdeen
-
Senior lecturer, University of South Australia
-
Professor and Laboratory Head of Physical Activity, Baker Heart and Diabetes Institute
-
Deputy Director Research and NHMRC Principal Research Fellow, The University of Queensland
-
Adjunct professor, Department of Health Policy & Management, George Washington University
-
Professor, School of Biotechnology and Biomolecular Sciences, UNSW Sydney
-
Senior Research Fellow, Glasgow Caledonian University
-
Chair of Human Nutrition, University of Glasgow
